University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

PF-04995274 and Emotional Processing in Un-medicated Depression

Phase 1

Completed

Conditions: Depression, Unipolar

Interventions: Drug: PF-04995274
Drug: Citalopram
Drug: Placebo oral capsule
Drug: Placebo Oral Tablet

First Posted Date: 2018-05-04

Last Posted Date: 2022-11-03

Lead Sponsor: University of Oxford

Target Recruit Count: 90

Registration Number: NCT03516604

Locations: 🇬🇧
University of Oxford, Oxford, Oxfordshire, United Kingdom

Evaluation of a Digital Microscope for Malaria

Completed

Conditions: Malaria

First Posted Date: 2018-05-01

Last Posted Date: 2020-09-03

Lead Sponsor: University of Oxford

Target Recruit Count: 2250

Registration Number: NCT03512678

Locations: 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

Improving SCBU Care for Preterm Babies

Completed

Conditions: Preterm Infant
Preterm Birth

Interventions: Other: Interviews of mothers
Other: Focus Group Discussion (FGD) of the medical staff
Other: Retrospective chart review

First Posted Date: 2018-04-30

Last Posted Date: 2023-01-09

Lead Sponsor: University of Oxford

Target Recruit Count: 36

Registration Number: NCT03512093

Locations: 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

Tambua Mapema Plus - to Discover HIV Infection Early and Prevent Onward Transmission

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Diagnostic Test: HIV-1 RNA testing

First Posted Date: 2018-04-26

Last Posted Date: 2023-11-13

Lead Sponsor: University of Oxford

Target Recruit Count: 2887

Registration Number: NCT03508908

Locations: 🇰🇪
KEMRI Mtwapa, Kilifi, Kenya

Investigating Genetic Risk for Type 1 Diabetes

Completed

Conditions: Diabetes Mellitus
Metabolic Disease
Endocrine System Diseases
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Autoimmune Diseases
Immune System Diseases

First Posted Date: 2018-04-20

Last Posted Date: 2021-09-24

Lead Sponsor: University of Oxford

Target Recruit Count: 15640

Registration Number: NCT03503747

Locations: 🇬🇧
Oxford University Hospitals NHS Trust, Oxford, United Kingdom

An Investigation of Levetiracetam in Alzheimer's Disease

Phase 2

Completed

Conditions: Alzheimer Disease
Epilepsy

Interventions: Drug: Placebo Oral Tablet
Drug: Levetiracetam

First Posted Date: 2018-04-05

Last Posted Date: 2024-04-24

Lead Sponsor: University of Oxford

Target Recruit Count: 8

Registration Number: NCT03489044

Locations: 🇬🇧
Nuffield Department of Clinical Neuroscience, Oxford, Oxfordshire, United Kingdom

Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children

Phase 3

Completed

Conditions: Plasmodium Falciparum

Interventions: Drug: Artemether-lumefantrine
Drug: Arterolane-piperaquine+mefloquine
Drug: Arterolane-piperaquine

First Posted Date: 2018-03-02

Last Posted Date: 2021-09-29

Lead Sponsor: University of Oxford

Target Recruit Count: 219

Registration Number: NCT03452475

Locations: 🇰🇪
Kilifi County Hospital, Kilifi, Kenya

Functional Magnetic Resonance Imaging (fMRI) Investigation Into Compulsivity in Anorexia

Not Applicable

Completed

Conditions: Anorexia Nervosa in Remission (Disorder)
Compulsive Behavior

Interventions: Other: MRI

First Posted Date: 2018-03-01

Last Posted Date: 2018-04-05

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT03450239

Locations: 🇬🇧
Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom

Eating Concerns and Compulsivity

Not Applicable

Completed

Conditions: Anorexia Nervosa in Remission
Eating Disorder

Interventions: Other: Volatility task

First Posted Date: 2018-03-01

Last Posted Date: 2018-07-06

Lead Sponsor: University of Oxford

Target Recruit Count: 82

Registration Number: NCT03450291

Locations: 🇬🇧
Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom

Lowering Events in Non-proliferative Retinopathy in Scotland

Phase 4

Completed

Conditions: Diabetic Retinopathy

Interventions: Drug: Fenofibrate 145 mg
Drug: Placebo Oral Tablet

First Posted Date: 2018-02-20

Last Posted Date: 2024-02-21

Lead Sponsor: University of Oxford

Target Recruit Count: 1151

Registration Number: NCT03439345

Locations: 🇬🇧
NHS Lothian, Edinburgh, United Kingdom
🇬🇧
NHS Grampian, Aberdeen, United Kingdom
🇬🇧
NHS Dumfries and Galloway, Dumfries, United Kingdom

and more 8 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy